These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2239477)

  • 1. Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.
    Calne DB; Eisen A
    Adv Neurol; 1990; 53():355-60. PubMed ID: 2239477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.
    Rinne JO; Rummukainen J; Paljärvi L; Säkö E; Mölsä P; Rinne UK
    Prog Clin Biol Res; 1989; 317():325-32. PubMed ID: 2602422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature].
    Norès JM; Biacabe B; Bonfils P
    Ann Med Interne (Paris); 2000 Mar; 151(2):97-106. PubMed ID: 10855362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do Alzheimer's disease and Parkinson's disease target the same neurons?
    Eggers AE
    Med Hypotheses; 2009 Jun; 72(6):698-700. PubMed ID: 19250756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?
    Blum-Degen D; Frölich L; Hoyer S; Riederer P
    J Neural Transm Suppl; 1995; 46():139-47. PubMed ID: 8821049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases.
    Helkala EL; Laulumaa V; Soininen H; Riekkinen PJ
    Ann Neurol; 1988 Aug; 24(2):214-7. PubMed ID: 3178177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?
    Sabbagh MN; Silverberg N; Bircea S; Majeed B; Samant S; Caviness JN; Reisberg B; Adler CH
    Parkinsonism Relat Disord; 2005 Aug; 11(5):311-5. PubMed ID: 15886042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuropathology of parkinsonism: an overview.
    Cornford ME; Chang L; Miller BL
    Brain Cogn; 1995 Aug; 28(3):321-41. PubMed ID: 8546858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
    Papapetropoulos S; Lieberman A; Gonzalez J; Mash DC
    Acta Neurol Scand; 2005 Jun; 111(6):353-9. PubMed ID: 15876335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium, neuronal death and neurological disease].
    Jiménez-Jiménez FJ; García-Ruiz PJ; de Bustos F
    Rev Neurol; 1996 Oct; 24(134):1199-209. PubMed ID: 8983715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of degenerative neurological disease.
    Cork LC; Kitt CA; Struble RG; Griffin JW; Price DL
    Prog Clin Biol Res; 1987; 229():241-69. PubMed ID: 3601987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.
    Koutsilieri E; Riederer P
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S329-31. PubMed ID: 18267259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serotonin transporter in Alzheimer's and Parkinson's disease.
    Mössner R; Schmitt A; Syagailo Y; Gerlach M; Riederer P; Lesch KP
    J Neural Transm Suppl; 2000; (60):345-50. PubMed ID: 11205152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.
    Antal A; Bodis-Wollner I
    Neurobiology (Bp); 1993; 1(2):101-22. PubMed ID: 8111350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD.
    Pyle A; Foltynie T; Tiangyou W; Lambert C; Keers SM; Allcock LM; Davison J; Lewis SJ; Perry RH; Barker R; Burn DJ; Chinnery PF
    Ann Neurol; 2005 Apr; 57(4):564-7. PubMed ID: 15786469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory impairment in motor neuron disease: a pilot study.
    Elian M
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):927-8. PubMed ID: 1744650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of cell death in neurodegenerative disorders: apropos of Parkinson disease].
    Agid Y
    C R Seances Soc Biol Fil; 1993; 187(1):37-46. PubMed ID: 8242421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The olfactory vector hypothesis of neurodegenerative disease: is it viable?
    Doty RL
    Ann Neurol; 2008 Jan; 63(1):7-15. PubMed ID: 18232016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.